Association between pre-eclampsia and inherited thrombophilias

Fetal and Pediatric Pathology

Volumn 32, Issue 3, 2013, Pages 213-217

  Deveer, Rüya ^a   Engin Ustun, Yaprak ^a   Akbaba, Eren ^a   Halisdemir, Beril ^a   Cakar, Esra ^a   Danisman, Nuri ^a   Mollamahmutoglu, Leyla ^a   Yesilyurt, Ahmet ^a   Candemir, Zuhal ^a  

^a Zekai Tahir Burak Women Health Research and Education Hospital   (Turkey)

Author keywords

Factor V Leiden; Inherited thrombophilia; Preeclampsia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INHERITANCE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ADULT; BIRTH WEIGHT; CARRIER STATE; CROSS-SECTIONAL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS; THROMBOPHILIA;

EID: 84877252808     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513815.2012.721475     Document Type: Article

References (26)

1. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989.
2. Salafia CM, Pezzullo JC, Lopez-Zeno JA, et al. Placental pathologic features of pretermpreeclampsia. Am J Obstet Gynecol 173: 1097-1105, 1995.
3. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191: 412-424, 2004.
4. Rasmussen A, Ravn P.High frequency of congenital thrombophilia inwomenwith pathological pregnancies? Acta Obstet Gynecol Scand 83: 808-817, 2004.
5. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101: 6-14, 2002.
6. Kocher O, Cirovic C, Malynn E, et al. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: A controlled study of 5,000 patients. Am J Clin Pathol 127: 68-75, 2007.
7. ACOG technical bulletin. Hypertension in pregnancy. Number 219-january 1996. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 53: 175-183, 1996.
8. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142: 159-167, 1982.
9. Cudihy D, Lee RV. The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 29: 576-582, 2009.
10. Dekker GA, de Vries JI, Doelitzsch PM, et al. Underlying disorders associatedwith severe early-onset preeclampsia. Am J Obstet Gynecol 173: 1042-1048, 1995.
11. Lin J, August P. Genetic thrombophilias and preeclampsia: A meta-analysis. Obstet Gynecol 105: 182-192, 2005.
12. Nurk E, Tell GS, Refsum H, et al. Leiden, pregnancy complications and adverse outcomes: the Hordal and Homocysteine Study. QJM 99: 289-298, 2006.
13. Simmonds RE, Ireland H, Lane DA, et al. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med 128: 8-14, 1998.
14. Comp PC, Thurnau GR, Welsh J, et al. Functional and immunologic protein S levels are decreased during pregnancy. Blood 68: 881-885, 1986.
15. Gilabert J, Fernandez JA, Espãna F, et al. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thromb Res 49: 319-329, 1988.
16. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylene tetrahydrofolate reductase gene and the risk of venous thromboembolism:meta- analysis of 31 studies. Pathophysiol Haemost Thromb 32: 51-58, 2002.
17. Brattstr̈om L, Wilcken DE, Ohrvik J, et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of ameta-analysis. Circulation 98(23): 2520-2526, 1998.
18. Tranquilli AL, Giannubilo SR, Dell'Uomo B, et al. Adverse pregnancy outcomes are associated with multiplematernal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol. 117: 144-147, 2004.
19. Riǵo J Jr, Nagy B, Fintor L, et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor VLeidenmutation and 5,10 methylenetetrahydrofolate reductase.Hypertens Pregnancy 19: 163-172, 2000.
20. UlukuşM, Eroǧu Z, Yeniel AO, et al. Frequency of factor V Leiden (G1691A), prothrombin (G20210A) and methylentetrahydrofolate reductase (C677T) genemutations in women with adverse pregnancy outcome. J Turkish-German Gynecol Assoc 7-3: 195-201, 2006.
21. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin #68: Antiphospholipid syndrome. Obstet Gynecol 106: 1113-1121, 2005.
22. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). JThromb Haemost 4: 295-306, 2006.
23. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: A systematic review. Br J Haematol 132: 171-196, 2006.
24. do Prado AD, Piovesan DM, Staub HL, et al. Association of anticardiolipin antibodies with preeclampsia: A systematic review and meta-analysis. Obstet Gynecol 116: 1433-1443, 2010.
25. Hirsh J, Guyatt G, Albers GW, et al. American College of Chest Physicians. Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 133 (6 Suppl): 71S-109S, 2008 Jun.
26. Erratum in: Chest. 134: 892, 2008.